Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Govaresh. 2013; 18 (1): 7-15
em Persa | IMEMR | ID: emr-193192

RESUMO

Background: the mechanism behind the apparent lack of effective antiviral immune response in patients with chronic hepatitis C virus [HCV] infection is poorly understood. Although multiple levels of abnormalities have been identified in innate and adaptive immunity, it is postulated that production of specific cytokines such as IL-10 may contribute to the induction and maintenance of HCV persistence. Production of IL-10 by CD4[+], CD25[+], and IL-10 [+] regulatory T cells with regulatory capacity [Tregs] appears to be one of the viral mechanisms that alter the antiviral immune response. As the first report, that attempts to mimic physiological forces that can occur during HCV infection, in this study we evaluate the ability of HCV-core antigens in increasing the frequency of CD4[+],CD25[+],IL-10[+] regulatory T cells


Materials and Methods: we analyzed peripheral blood mononuclear cells [PBMCs] from chronic HCV-infected patients [n=19] and normal controls [n=6] to determine the effect of the HCV-core antigen in the frequency of HCV-specific IL-10 production. PBMCs of different groups were isolated, cultured and stimulated with core antigen. Then, an in-house triple-stain flow cytometric method was used to investigate the frequency of CD4[+],CD25[+],IL-10 producing cells


Results: following incubation of PBMCs with HCV-core antigen, a population of CD4[+],CD25[+],IL-10[+] cells [regulatory T cells] increased. However we observed no increase in Tregs in the negative controls


Conclusion: the study supports the view that specific CD4[+],CD25[+],IL-10[+] T cells may be implicated in host immune tolerance during an HCV infection. It is likely that HCV vaccine candidates avoid epitopes that lead to strong IL-10 production

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA